Recombinant Human News Today

Sino Biological has the capability to produce GMP-grade cytokines which can play huge roles into cell therapy and clinical applications research.

A polypeptide known as human epidermal growth factor (EGF) binds to the receptor EGFR, which triggers a series of reactions that activate gene pathways

Currently, much research is ongoing to develop new and effective therapeutic drugs for the treatment of Heart failure. The treatment of HF is dependent on angiotensin-converting enzyme inhibitor

Currently, much research is ongoing to develop new and effective therapeutic drugs for the treatment of Heart failure. The treatment of HF is dependent on...

Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka. The commercial production in the SML was started in November 1989. Today SML, with a consolidated revenue of R 1,159.76 crore for the year 2021-22 against the previous years’ revenue of Rs 931.27 crore, has emerged as a global brand within manufacturing and supplying of affordable API and Formulation globally in different regulated markets. The Group with over 20 subsidiaries is now...

Sino Biological produces a wide range of IL-13 recombinant receptors for use in inflammatory disease and cancer research and development.

TOKYO (dpa-AFX) - Takeda Pharmaceutical Co. Ltd. (TAK) Thursday said its double-blind phase 3 trial of Hyqvia met the primary endpoint for the maintenance treatment of chronic inflammatory demyelinating

Exploring the mechanism of total flavonoids of Rhizoma Drynariae in treating rheumatoid arthritis

Bio-pharma Market is Going to Boom | Bayer, Novartis, Abbott Laboratories

Biopharmaceutical Market May See a Big Move | Major Giants Novartis, Pfizer, AbbVie